Table 4 The SUCRA values of included CPMs for secondary outcomes
CPMs | joint tenderness | joint swelling | morning stiffnes | ESR |
|---|---|---|---|---|
Biqi capsule | 48.4% | 57.7% | 54.3% | 67.0% |
Fufang-Fengshining capsule | 43.3% | 51.9% | 54.2% | 62.9% |
Jingulian capsule | 59.8% | 45.7% | – | 65.3% |
Kunxian capsule | 52.0% | 54.7% | 28.6% | 46.1% |
glucosides of Tripterygium Wilfordii tablet | 59.8% | 75.5% | 60.9% | 54.2% |
Leigongteng tablet | 41.8% | 54.4% | 54.2% | – |
Qiweitongbi oral liquid | – | 29.0% | 46.5% | 65.4% |
Wangbi tablet | 46.2% | 20.6% | 44.8% | 47.8% |
Yishenjuanbi pill | 74.7% | 52.7% | 56.4% | 51.5% |
Yuxuebi capsule | – | – | – | 22.3% |
Zhengqingfengtongning tablet | 42.2% | 55.0% | 64.9% | 39.7% |